These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 21454562

  • 21. Spatial approximation between two residues in the mid-region of secretin and the amino terminus of its receptor. Incorporation of seven sets of such constraints into a three-dimensional model of the agonist-bound secretin receptor.
    Dong M, Li Z, Zang M, Pinon DI, Lybrand TP, Miller LJ.
    J Biol Chem; 2003 Nov 28; 278(48):48300-12. PubMed ID: 14500709
    [Abstract] [Full Text] [Related]

  • 22. Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues.
    Harikumar KG, Lam PC, Dong M, Sexton PM, Abagyan R, Miller LJ.
    J Biol Chem; 2007 Nov 09; 282(45):32834-43. PubMed ID: 17827151
    [Abstract] [Full Text] [Related]

  • 23. Development of a biologically active secretin analogue incorporating a radioiodinatable photolabile p-(4-hydroxybenzoyl)phenylalanine in position 10.
    Dong M, Pinon DI, Miller LJ.
    Regul Pept; 2002 Nov 15; 109(1-3):181-7. PubMed ID: 12409231
    [Abstract] [Full Text] [Related]

  • 24. Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor.
    Dong M, Wang Y, Hadac EM, Pinon DI, Holicky E, Miller LJ.
    J Biol Chem; 1999 Jul 02; 274(27):19161-7. PubMed ID: 10383421
    [Abstract] [Full Text] [Related]

  • 25. Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.
    Dong M, Lam PC, Orry A, Sexton PM, Christopoulos A, Abagyan R, Miller LJ.
    J Biol Chem; 2016 Mar 04; 291(10):5172-84. PubMed ID: 26740626
    [Abstract] [Full Text] [Related]

  • 26. Structural basis for ligand recognition of incretin receptors.
    Underwood CR, Parthier C, Reedtz-Runge S.
    Vitam Horm; 2010 Mar 04; 84():251-78. PubMed ID: 21094903
    [Abstract] [Full Text] [Related]

  • 27. Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
    Dong M, Lam PC, Pinon DI, Sexton PM, Abagyan R, Miller LJ.
    Mol Pharmacol; 2008 Aug 04; 74(2):413-22. PubMed ID: 18467541
    [Abstract] [Full Text] [Related]

  • 28. Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors.
    Dong M, Pinon DI, Asmann YW, Miller LJ.
    Mol Pharmacol; 2006 Jul 04; 70(1):206-13. PubMed ID: 16531505
    [Abstract] [Full Text] [Related]

  • 29. Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor.
    Zang M, Dong M, Pinon DI, Ding XQ, Hadac EM, Li Z, Lybrand TP, Miller LJ.
    Mol Pharmacol; 2003 May 04; 63(5):993-1001. PubMed ID: 12695527
    [Abstract] [Full Text] [Related]

  • 30. Molecular evolution of GPCRs: GLP1/GLP1 receptors.
    Hwang JI, Yun S, Moon MJ, Park CR, Seong JY.
    J Mol Endocrinol; 2014 Jun 04; 52(3):T15-27. PubMed ID: 24598200
    [Abstract] [Full Text] [Related]

  • 31. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
    Zhao LH, Yin Y, Yang D, Liu B, Hou L, Wang X, Pal K, Jiang Y, Feng Y, Cai X, Dai A, Liu M, Wang MW, Melcher K, Xu HE.
    J Biol Chem; 2016 Jul 15; 291(29):15119-30. PubMed ID: 27226600
    [Abstract] [Full Text] [Related]

  • 32. Molecular approximation between a residue in the amino-terminal region of calcitonin and the third extracellular loop of the class B G protein-coupled calcitonin receptor.
    Dong M, Pinon DI, Cox RF, Miller LJ.
    J Biol Chem; 2004 Jul 23; 279(30):31177-82. PubMed ID: 15155765
    [Abstract] [Full Text] [Related]

  • 33. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
    Gelling RW, Wheeler MB, Xue J, Gyomorey S, Nian C, Pederson RA, McIntosh CH.
    Endocrinology; 1997 Jun 23; 138(6):2640-3. PubMed ID: 9165060
    [Abstract] [Full Text] [Related]

  • 34. Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe.
    Ding XQ, Dolu V, Hadac EM, Holicky EL, Pinon DI, Lybrand TP, Miller LJ.
    J Biol Chem; 2001 Feb 09; 276(6):4236-44. PubMed ID: 11050076
    [Abstract] [Full Text] [Related]

  • 35. The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity.
    Wilmen A, Göke B, Göke R.
    FEBS Lett; 1996 Nov 25; 398(1):43-7. PubMed ID: 8946950
    [Abstract] [Full Text] [Related]

  • 36. Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping.
    Dong M, Xu X, Ball AM, Makhoul JA, Lam PC, Pinon DI, Orry A, Sexton PM, Abagyan R, Miller LJ.
    FASEB J; 2012 Dec 25; 26(12):5092-105. PubMed ID: 22964305
    [Abstract] [Full Text] [Related]

  • 37. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
    Van Eyll B, Göke B, Wilmen A, Göke R.
    Peptides; 1996 Dec 25; 17(4):565-70. PubMed ID: 8804062
    [Abstract] [Full Text] [Related]

  • 38. Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus.
    Dong M, Zang M, Pinon DI, Li Z, Lybrand TP, Miller LJ.
    Mol Endocrinol; 2002 Nov 25; 16(11):2490-501. PubMed ID: 12403838
    [Abstract] [Full Text] [Related]

  • 39. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C, Wootten D, Simms J, Miller LJ, Christopoulos A, Sexton PM.
    J Pharmacol Exp Ther; 2015 Apr 25; 353(1):52-63. PubMed ID: 25630467
    [Abstract] [Full Text] [Related]

  • 40. Insights into the impact of phenolic residue incorporation at each position along secretin for receptor binding and biological activity.
    Dong M, Pinon DI, Miller LJ.
    Regul Pept; 2013 Jan 10; 180():5-11. PubMed ID: 23142313
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.